Literature DB >> 18414074

A patient with adult erythermalgia: evidence suggesting an autoimmune etiology.

Autumn L Jackson1, John A Oates.   

Abstract

We report the case of a woman with a combination of erythermalgia, idiopathic thrombocytopenic purpura, and vitamin B-12 deficiency with positive parietal cell antibodies. The patient was treated with intravenous administration of immunoglobulins together with small doses of prednisone, which resulted in an improvement in her platelet counts, rise in her vitamin B12 levels, and resolution of her painful discolored digits. These findings suggest an underlying autoimmune component to the development of erythermalgia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18414074      PMCID: PMC3418791          DOI: 10.1097/MAJ.0b013e31812f65e7

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  11 in total

Review 1.  Erythromelalgia--a mysterious condition?

Authors:  C Mørk; K Kvernebo
Journal:  Arch Dermatol       Date:  2000-03

2.  Erythromelalgia in a patient with idiopathic thrombocytopenic purpura.

Authors:  J Rey; E Crétel; R Jean; J M Durand
Journal:  Br J Dermatol       Date:  2003-01       Impact factor: 9.302

3.  Secondary erythermalgia associated with an autoimmune disorder of undetermined significance.

Authors:  J P Drenth; J J Michiels; T Van Joost; V D Vuzevski
Journal:  Dermatology       Date:  1995       Impact factor: 5.366

4.  Erythromelalgia.

Authors:  G H Thompson; G Hahn; M Rang
Journal:  Clin Orthop Relat Res       Date:  1979-10       Impact factor: 4.176

Review 5.  Classification and diagnosis of erythromelalgia and erythermalgia.

Authors:  J J Michiels; J P Drenth; P J Van Genderen
Journal:  Int J Dermatol       Date:  1995-02       Impact factor: 2.736

Review 6.  Paraneoplastic rheumatic syndromes.

Authors:  A G Fam
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  2000-09       Impact factor: 4.098

7.  Natural history of erythromelalgia: presentation and outcome in 168 patients.

Authors:  M D Davis; W M O'Fallon; R S Rogers; T W Rooke
Journal:  Arch Dermatol       Date:  2000-03

8.  The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia-a double-blind, crossover, placebo-compared study.

Authors:  Cato Mørk; E Göran Salerud; Claes L Asker; Knut Kvernebo
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

9.  Presence of specific IgG antibody to the A type inclusions of erythromelalgia-related poxvirus in the sera of patients with epidemic erythromelalgia.

Authors:  Z M Zheng; S Specter; H Friedman
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

10.  Prostacyclin reduces symptoms and sympathetic dysfunction in erythromelalgia in a double-blind randomized pilot study.

Authors:  Ole M Kalgaard; Cato Mørk; Knut Kvernebo
Journal:  Acta Derm Venereol       Date:  2003       Impact factor: 4.437

View more
  4 in total

1.  Fish Oil and BCQ™ as a Novel Treatment Approach to Primary Erythromelalgia: A Case Study.

Authors:  Jillian Moehle; Leslie Fuller; Angela Hardin
Journal:  Integr Med (Encinitas)       Date:  2021-08

2.  Successful treatment of adult-onset erythromelalgia with steroid pulse and pregabalin.

Authors:  Aya Kakizaki; Taku Fujimura; Yumi Kambayashi; Akiko Watabe; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-09-13

3.  Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial.

Authors:  Bianca T A de Greef; Margot Geerts; Janneke G J Hoeijmakers; Catharina G Faber; Ingemar S J Merkies
Journal:  Trials       Date:  2016-07-20       Impact factor: 2.279

Review 4.  Current pain management strategies for patients with erythromelalgia: a critical review.

Authors:  See Wan Tham; Marian Giles
Journal:  J Pain Res       Date:  2018-08-30       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.